ABP
Price
$3.90
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Capitalization
10.58M
Intraday BUY SELL Signals
TRAW
Price
$1.77
Change
+$0.16 (+9.94%)
Updated
Jan 14 closing price
Capitalization
14.14M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABP vs TRAW

Header iconABP vs TRAW Comparison
Open Charts ABP vs TRAWBanner chart's image
Abpro Holdings
Price$3.90
Change-$0.00 (-0.00%)
Volume$2.08K
Capitalization10.58M
Traws Pharma
Price$1.77
Change+$0.16 (+9.94%)
Volume$1.27M
Capitalization14.14M
ABP vs TRAW Comparison Chart in %
ABP
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABP vs. TRAW commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Hold and TRAW is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ABP: $3.89 vs. TRAW: $1.77)
Brand notoriety: ABP and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 10% vs. TRAW: 252%
Market capitalization -- ABP: $10.58M vs. TRAW: $14.14M
ABP [@Biotechnology] is valued at $10.58M. TRAW’s [@Biotechnology] market capitalization is $14.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileTRAW’s FA Score has 2 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 2 green, 3 red.
According to our system of comparison, TRAW is a better buy in the long-term than ABP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 4 TA indicator(s) are bullish while TRAW’s TA Score has 4 bullish TA indicator(s).

  • ABP’s TA Score: 4 bullish, 3 bearish.
  • TRAW’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABP is a better buy in the short-term than TRAW.

Price Growth

ABP (@Biotechnology) experienced а -12.47% price change this week, while TRAW (@Biotechnology) price change was +32.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRAW($14.1M) has a higher market cap than ABP($10.6M). TRAW YTD gains are higher at: 56.637 vs. ABP (-7.920). ABP has higher annual earnings (EBITDA): -10.1M vs. TRAW (-15.77M). TRAW has more cash in the bank: 6.42M vs. ABP (328K). TRAW has higher revenues than ABP: TRAW (2.85M) vs ABP (0).
ABPTRAWABP / TRAW
Capitalization10.6M14.1M75%
EBITDA-10.1M-15.77M64%
Gain YTD-7.92056.637-14%
P/E RatioN/A0.50-
Revenue02.85M-
Total Cash328K6.42M5%
Total Debt147KN/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPTRAW
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 8 days ago
39%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 28 days ago
59%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFST26.600.43
+1.64%
Business First Bancshares
WEC107.071.11
+1.05%
WEC Energy Group
CNO42.430.23
+0.55%
CNO Financial Group
FEBO1.24-0.01
-0.80%
Fenbo Holdings Limited
CMTL5.81-0.07
-1.19%
Comtech Telecommunications Corp

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and QSI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and QSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
+0.13%
QSI - ABP
27%
Poorly correlated
N/A
TRAW - ABP
26%
Poorly correlated
+9.94%
ATYR - ABP
25%
Poorly correlated
+1.67%
ARTV - ABP
24%
Poorly correlated
+3.91%
RNTX - ABP
24%
Poorly correlated
-0.88%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with VTGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
+9.94%
VTGN - TRAW
45%
Loosely correlated
+2.32%
SLGL - TRAW
42%
Loosely correlated
+7.71%
VIR - TRAW
35%
Loosely correlated
+8.08%
IMTX - TRAW
34%
Loosely correlated
+4.80%
ORMP - TRAW
34%
Loosely correlated
+7.37%
More